HELIUS MEDICAL TECHNOLOGIES (HSDT) Stock Price, Quote, News and Overview
NASDAQ:HSDT - Nasdaq - US42328V8019 - Common Stock - Currency: USD
HSDT Quote, Performance and Key Statistics
NASDAQ:HSDT (2/21/2025, 3:21:00 PM)
0.52
-0.02 (-3.53%)
The current stock price of HSDT is 0.52 USD. In the past month the price decreased by -34.27%. In the past year, price decreased by -90.61%.
HSDT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.9 | 234.12B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.72 | 211.03B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.71 | 154.28B | ||
| SYK | STRYKER CORP | 31.35 | 145.69B | ||
| MDT | MEDTRONIC PLC | 16.86 | 115.47B | ||
| BDX | BECTON DICKINSON AND CO | 16.33 | 65.21B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.07 | 43.37B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.28 | 41.61B | ||
| IDXX | IDEXX LABORATORIES INC | 40.62 | 37.41B | ||
| DXCM | DEXCOM INC | 53.98 | 34.79B | ||
| RMD | RESMED INC | 26.16 | 33.96B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.44 | 23.93B |
Related stock screener links
About HSDT
Company Profile
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 22 full-time employees. The company went IPO on 2014-06-27. The company is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. The company develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
Company Info
HELIUS MEDICAL TECHNOLOGIES
642 Newtown Yardley Road
Newtown PENNSYLVANIA 18940 US
CEO: Dane C. Andreeff
Employees: 22
Company Website: https://heliusmedical.com/
Investor Relations: https://heliusmedical.com/index.php/investor-relations/overview
Phone: 12159446100
HELIUS MEDICAL TECHNOLOGIES / HSDT FAQ
What is the stock price of HELIUS MEDICAL TECHNOLOGIES today?
The current stock price of HSDT is 0.52 USD. The price decreased by -3.53% in the last trading session.
What is the ticker symbol for HELIUS MEDICAL TECHNOLOGIES stock?
The exchange symbol of HELIUS MEDICAL TECHNOLOGIES is HSDT and it is listed on the Nasdaq exchange.
On which exchange is HSDT stock listed?
HSDT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for HELIUS MEDICAL TECHNOLOGIES stock?
6 analysts have analysed HSDT and the average price target is 4.08 USD. This implies a price increase of 684.62% is expected in the next year compared to the current price of 0.52. Check the HELIUS MEDICAL TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HELIUS MEDICAL TECHNOLOGIES worth?
HELIUS MEDICAL TECHNOLOGIES (HSDT) has a market capitalization of 1.94M USD. This makes HSDT a Nano Cap stock.
How many employees does HELIUS MEDICAL TECHNOLOGIES have?
HELIUS MEDICAL TECHNOLOGIES (HSDT) currently has 22 employees.
What are the support and resistance levels for HELIUS MEDICAL TECHNOLOGIES (HSDT) stock?
HELIUS MEDICAL TECHNOLOGIES (HSDT) has a support level at 0.53 and a resistance level at 0.57. Check the full technical report for a detailed analysis of HSDT support and resistance levels.
Is HELIUS MEDICAL TECHNOLOGIES (HSDT) expected to grow?
The Revenue of HELIUS MEDICAL TECHNOLOGIES (HSDT) is expected to decline by -38.12% in the next year. Check the estimates tab for more information on the HSDT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HELIUS MEDICAL TECHNOLOGIES (HSDT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HSDT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HSDT, evaluating the profitability, health, valuation and growth aspects
- HELIUS MEDICAL TECHNOLOGIES (HSDT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HELIUS MEDICAL TECHNOLOGIES (HSDT) Sales and EPS estimates to see what analysts future expectations are.
- HELIUS MEDICAL TECHNOLOGIES (HSDT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HELIUS MEDICAL TECHNOLOGIES (HSDT) Insider and Institutional Ownership to learn about the owners and their transactions.
- HELIUS MEDICAL TECHNOLOGIES (HSDT) Stock Chart to make your own analysis
- HELIUS MEDICAL TECHNOLOGIES (HSDT) Latest news and press-releases to stay up to date.
Does HELIUS MEDICAL TECHNOLOGIES (HSDT) stock pay dividends?
HSDT does not pay a dividend.
When does HELIUS MEDICAL TECHNOLOGIES (HSDT) report earnings?
HELIUS MEDICAL TECHNOLOGIES (HSDT) will report earnings on 2025-03-26, after the market close.
What is the Price/Earnings (PE) ratio of HELIUS MEDICAL TECHNOLOGIES (HSDT)?
HELIUS MEDICAL TECHNOLOGIES (HSDT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.18).
What is the Short Interest ratio of HELIUS MEDICAL TECHNOLOGIES (HSDT) stock?
The outstanding short interest for HELIUS MEDICAL TECHNOLOGIES (HSDT) is 1.58% of its float. Check the ownership tab for more information on the HSDT short interest.
HSDT Technical Analysis
HSDT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HSDT. HSDT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
HSDT Financial Highlights
Over the last trailing twelve months HSDT reported a non-GAAP Earnings per Share(EPS) of -6.18. The EPS increased by 71.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -158.62% | ||
| ROE | -233.19% | ||
| Debt/Equity | 0 |
HSDT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to HSDT. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 60.22% and a revenue growth -38.12% for HSDT